XML 1018 R25.htm IDEA: XBRL DOCUMENT v2.4.0.6
Guarantor/Non-Guarantor Subsidiary Financial Information
12 Months Ended
Dec. 31, 2011
Guarantor/Non-Guarantor Subsidiary Financial Information [Abstract]  
Guarantor/Non-Guarantor Subsidiary Financial Information

18. Guarantor/Non-Guarantor Subsidiary Financial Information

The Company and certain of its U.S. subsidiaries guarantee debt issued by its wholly owned subsidiaries Hexion Nova Scotia, ULC and Hexion U.S. Finance Corporation (together, the "Subsidiary Issuers"), which includes the 8.875% first priority senior secured notes due 2018, the floating rate second-priority senior secured notes due 2014 and the 9% second-priority notes due 2020.

The following information contains the condensed consolidating financial information for MSC (the parent), the Subsidiary Issuers, the combined subsidiary guarantors (Momentive Specialty Chemical Investments Inc.; Borden Chemical Foundry; LLC, Lawter International, Inc.; HSC Capital Corporation; Momentive International, Inc.; Momentive CI Holding Company; NL COOP Holdings LLC and Oilfield Technology Group, Inc.) and the combined non-guarantor subsidiaries, which includes all of the Company's foreign subsidiaries and HAI (prior to the deconsolidation of this entity).

All of the subsidiary issuers and subsidiary guarantors are 100% owned by MSC. All guarantees are full and unconditional, and are joint and several, subject to certain customary release provisions set forth in the applicable indenture. There are no significant restrictions on the ability of the Company to obtain funds from its domestic subsidiaries by dividend or loan. While the Company's Australian, New Zealand and Brazilian subsidiaries are restricted in the payment of dividends and intercompany loans due to the terms of their credit facilities, there are no material restrictions on the Company's ability to obtain cash from the remaining non-guarantor subsidiaries.

This information includes allocations of corporate overhead to the combined non-guarantor subsidiaries based on net sales. Income tax expense has been provided on the combined non-guarantor subsidiaries based on actual effective tax rates.

 

MOMENTIVE SPECIALTY CHEMICALS INC.

Notes to Consolidated Financial Statements

(dollars in millions)

YEAR ENDED DECEMBER 31, 2011

CONDENSED CONSOLIDATING STATEMENT OF OPERATIONS

 

    Momentive
Specialty
Chemicals Inc.
    Subsidiary
Issuers
    Combined
Subsidiary
Guarantors
    Combined
Non-

Guarantor
Subsidiaries
    Eliminations     Consolidated  

Net sales

  $ 2,246      $ —        $ —        $ 3,254      $ (293   $ 5,207   

Cost of sales

    1,856        —          —          2,910        (293     4,473   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Gross profit

    390        —          —          344        —          734   

Selling, general and administrative expense

    110        —          —          225        —          335   

Asset impairments

    4        —          —          28        —          32   

Business realignment costs

    2        —          —          13        —          15   

Other operating (income) expense, net

    (20     —          (1     5        —          (16
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Operating income

    294        —          1        73        —          368   

Interest expense, net

    69        150        —          43        —          262   

Intercompany interest expense (income), net

    121        (170     (1     50        —          —     

Other non-operating expense (income), net

    8        —          —          (5     —          3   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Income (loss) before income tax, earnings from unconsolidated entities

    96        20        2        (15     —          103   

Income tax (benefit) expense

    (8     1        —          10        —          3   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Income (loss) before earnings from unconsolidated entities

    104        19        2        (25     —          100   

Earnings from unconsolidated entities, net of taxes

    32        —          22        1        (39     16   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net income (loss) from continuing operations

    136        19        24        (24     (39     116   

Net (loss) income from discontinued operations, net of tax

    (18     —          —          20        —          2   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net income (loss)

  $ 118      $ 19      $ 24      $ (4   $ (39   $ 118   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

MOMENTIVE SPECIALTY CHEMICALS INC.

Notes to Consolidated Financial Statements

(dollars in millions)

YEAR ENDED DECEMBER 31, 2010

CONDENSED CONSOLIDATING STATEMENT OF OPERATIONS

 

    Momentive
Specialty
Chemicals Inc.
    Subsidiary
Issuers
    Combined
Subsidiary
Guarantors
    Combined
Non-

Guarantor
Subsidiaries
    Eliminations     Consolidated  

Net sales

  $ 2,002      $ —        $ —        $ 2,934      $ (339   $ 4,597   

Cost of sales

    1,618        —          —          2,587        (339     3,866   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Gross profit

    384        —          —          347        —          731   

Selling, general and administrative expense

    117        —          —          215        —          332   

Terminated merger and settlement income, net

    (171     —          —          —          —          (171

Business realignment costs

    5        —          —          15        —          20   

Other operating expense (income), net

    6        —          —          (2     —          4   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Operating income

    427        —          —          119        —          546   

Interest expense, net

    92        144        —          40        —          276   

Loss on extinguishment of debt

    7        5        —          18        —          30   

Intercompany interest expense (income), net

    123        (169     (1     47        —          —     

Other non-operating (income) expense, net

    (18     8        —          6        —          (4
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Income before income tax, earnings from unconsolidated entities

    223        12        1        8        —          244   

Income tax (benefit) expense

    (11     10        —          36        —          35   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Income (loss) before earnings from unconsolidated entities

    234        2        1        (28     —          209   

(Loss) earnings from unconsolidated entities, net of taxes

    (13     —          (5     —          26        8   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net income (loss) from continuing operations

    221        2        (4     (28     26        217   

Net (loss) income from discontinued operations, net of tax

    (7     —          —          4        —          (3
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net income (loss)

  $ 214      $ 2      $ (4   $ (24   $ 26      $ 214   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

MOMENTIVE SPECIALTY CHEMICALS INC.

Notes to Consolidated Financial Statements

(dollars in millions)

YEAR ENDED DECEMBER 31, 2009

CONDENSED CONSOLIDATING STATEMENT OF OPERATIONS

 

    Momentive
Specialty
Chemicals Inc.
    Subsidiary
Issuers
    Combined
Subsidiary
Guarantors
    Combined
Non-

Guarantor
Subsidiaries
    Eliminations     Consolidated  

Net sales

  $ 1,418      $ —        $ —        $ 2,475      $ (344   $ 3,549   

Cost of sales

    1,248        —          —          2,173        (344     3,077   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Gross profit

    170        —          —          302        —          472   

Selling, general and administrative expense

    81        —          —          224        —          305   

Terminated merger and settlement (income) expense, net

    (64     —          —          2        —          (62

Asset impairments

    37        —          —          12        —          49   

Business realignment costs

    14        —          —          23        —          37   

Other operating expense (income), net

    7        —          (1     1        —          7   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Operating income

    95        —          1        40        —          136   

Interest expense, net

    130        62        —          31        —          223   

Gain on extinguishment of debt

    (76     (148     —          —          —          (224

Intercompany interest expense (income), net

    67        (82     (1     16        —          —     

Other non-operating (income) expense, net

    (6     7        1        (2     —          —     
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

(Loss) income before income tax, earnings from unconsolidated entities

    (20     161        1        (5     —          137   

Income tax (benefit) expense

    (4     6        —          (10     —          (8
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

(Loss) income before earnings from unconsolidated entities

    (16     155        1        5        —          145   

Earnings from unconsolidated entities, net of taxes

    145        —          2        2        (147     2   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net income from continuing operations

    129        155        3        7        (147     147   

Net loss from discontinued operations, net of tax

    (12     —          —          (18     —          (30
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net income (loss)

    117        155        3        (11     (147     117   

Net income attributable to noncontrolling interest

    (3     —          —          —          —          (3
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Net income (loss) attributable to Momentive Specialty Chemicals Inc.

  $ 114      $ 155      $ 3      $ (11   $ (147   $ 114   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

MOMENTIVE SPECIALTY CHEMICALS INC.

Notes to Consolidated Financial Statements

(dollars in millions)

DECEMBER 31, 2011

CONDENSED CONSOLIDATING BALANCE SHEET

 

    Momentive
Specialty
Chemicals Inc.
    Subsidiary
Issuers
    Combined
Subsidiary
Guarantors
    Combined
Non-

Guarantor
Subsidiaries
    Eliminations     Consolidated  

Assets

           

Current assets

           

Cash and cash equivalents (including restricted cash of $0 and $3, respectively)

  $ 221      $ —        $ —        $ 210      $ —        $ 431   

Short-term investments

    —          —          —          7        —          7   

Accounts receivable, net

    206        —          —          386        —          592   

Inventories:

           

Finished and in-process goods

    116        —          —          138        —          254   

Raw materials and supplies

    33        —          —          70        —          103   

Other current assets

    27        —          —          45        —          72   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total current assets

    603        —          —          856        —          1,459   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Other assets

    107        36        40        89        (103     169   

Property and equipment, net

    504        —          —          705        —          1,209   

Goodwill

    93        —          —          74        —          167   

Other intangible assets, net

    59        —          —          45        —          104   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total assets

  $ 1,366      $ 36      $ 40      $ 1,769      $ (103   $ 3,108   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Liabilities and (Deficit) Equity

           

Current liabilities

           

Accounts and drafts payable

  $ 134      $ —        $ —        $ 259      $ —        $ 393   

Intercompany accounts (receivable) payable

    (24     (42     1        65        —          —     

Debt payable within one year

    17        —          —          100        —          117   

Intercompany loans payable (receivable)

    35        —          —          (35     —          —     

Loans payable to affiliates

    2        —          —          —          —          2   

Interest payable

    14        44        —          3        —          61   

Income taxes payable

    1        —          —          14        —          15   

Accrued payroll and incentive compensation

    26        —          —          31        —          57   

Other current liabilities

    69        —          —          63        —          132   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total current liabilities

    274        2        1        500        —          777   

Long-term debt

    1,134        1,688        —          598        —          3,420   

Intercompany loans payable (receivable)

    1,254        (1,903     (16     665        —          —     

Long-term pension and post employment benefit obligations

    99        —          —          124        —          223   

Deferred income taxes

    30        2        —          40        —          72   

Other long-term liabilities

    116        6        —          34        —          156   

Advance from affiliates

    225        —          —          —          —          225   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total liabilities

    3,132        (205     (15     1,961        —          4,873   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total Momentive Specialty Chemicals Inc. shareholder's (deficit) equity

    (1,766     241        55        (193     (103     (1,766

Noncontrolling interest

    —          —          —          1        —          1   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total (deficit) equity

    (1,766     241        55        (192     (103     (1,765
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total liabilities and (deficit) equity

  $ 1,366      $ 36      $ 40      $ 1,769      $ (103   $ 3,108   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

MOMENTIVE SPECIALTY CHEMICALS INC.

Notes to Consolidated Financial Statements

(dollars in millions)

DECEMBER 31, 2010

CONDENSED CONSOLIDATING BALANCE SHEET

 

    Momentive
Specialty
Chemicals Inc.
    Subsidiary
Issuers
    Combined
Subsidiary
Guarantors
    Combined
Non-

Guarantor
Subsidiaries
    Eliminations     Consolidated  

Assets

           

Current assets

           

Cash and cash equivalents (including restricted cash of $0 and $6, respectively)

  $ 56      $ —        $ —        $ 130      $ —        $ 186   

Short-term investments

    —          —          —          6        —          6   

Accounts receivable, net

    115        —          —          412        —          527   

Inventories:

           

Finished and in-process goods

    122        —          —          144        —          266   

Raw materials and supplies

    35        —          —          74        —          109   

Other current assets

    31        —          —          48        —          79   

Discontinued operations

    102        —          —          141        —          243   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total current assets

    461        —          —          955        —          1,416   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Other assets

    6        41        30        73        3        153   

Property and equipment, net

    497        —          —          770        —          1,267   

Goodwill

    93        —          —          76        —          169   

Other intangible assets, net

    62        —          —          70        —          132   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total assets

  $ 1,119      $ 41      $ 30      $ 1,944      $ 3      $ 3,137   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Liabilities and (Deficit) Equity

           

Current liabilities

           

Accounts and drafts payable

  $ 137      $ —        $ —        $ 277      $ —        $ 414   

Intercompany accounts (receivable) payable

    (140     (46     —          186        —          —     

Debt payable within one year

    25        —          —          57        —          82   

Intercompany loans (receivable) payable

    (97     —          —          97        —          —     

Loans payable to affiliates

    2        —          —          —          —          2   

Interest payable

    21        46        —          2        —          69   

Income taxes payable

    7        —          —          17        —          24   

Accrued payroll and incentive compensation

    28        —          —          37        —          65   

Other current liabilities

    90        —          —          60        —          150   

Discontinued operations

    37        —          —          22        —          59   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total current liabilities

    110        —          —          755        —          865   

Long-term debt

    1,152        1,687        —          649        —          3,488   

Affiliated long-term debt

    80        —          —          20        —          100   

Intercompany loans payable (receivable)

    1,352        (1,887     (15     550        —          —     

Long-term pension and post employment benefit obligations

    83        —          —          125        —          208   

Deferred income taxes

    35        2        —          73        —          110   

Other long-term liabilities

    104        6        —          50        —          160   

Advance from affiliates

    225        —          —          —          —          225   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total liabilities

    3,141        (192     (15     2,222        —          5,156   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total Momentive Specialty Chemicals Inc. shareholder's (deficit) equity

    (2,022     233        45        (281     3        (2,022

Noncontrolling interest

    —          —          —          3        —          3   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total (deficit) equity

    (2,022     233        45        (278     3        (2,019
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Total liabilities and (deficit) equity

  $ 1,119      $ 41      $ 30      $ 1,944      $ 3      $ 3,137   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

 

MOMENTIVE SPECIALTY CHEMICALS INC.

Notes to Consolidated Financial Statements

(dollars in millions)

YEAR ENDED DECEMBER 31, 2011

CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS

 

    Momentive
Specialty
Chemicals Inc.
    Subsidiary
Issuers
    Combined
Subsidiary
Guarantors
    Combined
Non-

Guarantor
Subsidiaries
    Eliminations     Consolidated  

Cash flows (used in) provided by operating activities

  $ (72   $ 8      $ 19      $ 196      $ —        $ 151   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Cash flows provided by (used in) investing activities

           

Capital expenditures

    (74     —          —          (65     —          (139

Capitalized interest

    (1     —          —          —          —          (1

Purchases of debt securities, net

    —          —          —          (2     —          (2

Change in restricted cash

    —          —          —          3        —          3   

Proceeds from the return of capital from subsidiary

    69 (a)     —          —          —          (69     —     

Dividends from subsidiaries

    60        —          —          —          (60     —     

Capital contribution to subsidiary

    (11     —          (19     —          30        —     

Proceeds from the sale of businesses, net of cash transferred

    49        —          —          124        —          173   

Proceeds from the sale of assets

    2        —          —          1        —          3   

Dividends from unconsolidated affiliates, net of funds remitted

    12        —          12        (4     (12     8   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
    106        —          (7     57        (111     45   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Cash flows provided by (used in) financing activities

           

Net short-term debt (repayments) borrowings

    (7     —          —          21        —          14   

Borrowings of long-term debt

    164        —          —          332        —          496   

Repayments of long-term debt

    (182     —          —          (356     —          (538

Repayments of affiliated debt

    (80     —          —          (20     —          (100

Return of capital to parent

    —          —          —          (69 )(a)     69        —     

Net intercompany loan borrowings (repayments)

    51        4        —          (55     —          —     

Capital contribution from parent

    189        —          —          30        (30     189   

Payments of dividends on common stock

    (2     (12     (12     (48     72        (2

Long-term debt and credit facility financing fees

    (2     —          —          —          —          (2
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
    131        (8     (12     (165     111        57   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Effect of exchange rates on cash and cash equivalents

    —          —          —          (5     —          (5
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Increase in cash and cash equivalents

    165        —          —          83        —          248   

Cash and cash equivalents (unrestricted) at beginning of year

    56        —          —          124        —          180   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Cash and cash equivalents (unrestricted) at end of year

  $ 221      $      $      $ 207      $      $ 428   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

(a) During the year ended December 31, 2011, Momentive Specialty Chemicals Inc. contributed receivables of $69 to a non-guarantor subsidiary as capital contributions, resulting in a non-cash transaction. During the year ended December 31, 2011, the non-guarantor subsidiary sold the contributed receivables to certain banks under various supplier financing agreements. The cash proceeds were returned to Momentive Specialty Chemicals Inc. by the non-guarantor subsidiary as a return of capital. The sale of receivables has been included within cash flows from operating activities on the Combined non-guarantor subsidiaries. The return of the cash proceeds from the sale of receivables has been included as a financing outflow and an investing inflow on the Combined Non-Guarantor Subsidiaries and Momentive Specialty Chemicals Inc., respectively.

 

MOMENTIVE SPECIALTY CHEMICALS INC.

Notes to Consolidated Financial Statements

(dollars in millions)

YEAR ENDED DECEMBER 31, 2010

CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS

 

    Momentive
Specialty
Chemicals Inc.
    Subsidiary
Issuers
    Combined
Subsidiary
Guarantors
    Combined
Non-

Guarantor
Subsidiaries
    Eliminations     Consolidated  

Cash flows (used in) provided by operating activities

  $ (465   $ 19      $ —        $ 491      $ —        $ 45   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Cash flows provided by (used in) investing activities

           

Capital expenditures

    (52     —          —          (67     —          (119

Capitalized interest

    —          —          —          (1     —          (1

Proceeds from matured debt securities, net

    —          —          —          4        —          4   

Change in restricted cash

    —          —          —          2        —          2   

Proceeds from the return of capital from subsidiary

    367 (a)     —          —          —          (367     —     

Dividends from subsidiaries

    18        —          1        —          (19     —     

Deconsolidation of variable interest entity

    —          —          —          (4     —          (4

Proceeds from the sale of assets

    6        —          —          8        —          14   

Investment in unconsolidated affiliates, net

    —          —          4        1        —          5   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
    339        —          5        (57     (386     (99
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Cash flows provided by (used in) financing activities

           

Net short-term debt borrowings (repayments)

    3        —          —          (10     —          (7

Borrowings of long-term debt

    290        1,433        —          633        —          2,356   

Repayments of long-term debt

    (1,108     (406     —          (663     —          (2,177

Repayments of affiliated debt

    (3     —          —          —          —          (3

Return of capital to parent

    —          —          —          (367 )(a)     367        —     

Net intercompany loan borrowings (repayments)

    987        (973     —          (14     —          —     

Payments of dividends on common stock

    —          (10     (5     (4     19        —     

Long-term debt and credit facility financing fees

    (9     (63     —          —          —          (72
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
    160        (19     (5     (425     386        97   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Effect of exchange rates on cash and cash equivalents

    —          —          —          2        —          2   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Increase in cash and cash equivalents

    34        —          —          11        —          45   

Cash and cash equivalents (unrestricted) at beginning of year

    22        —          —          113        —          135   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Cash and cash equivalents (unrestricted) at end of year

  $ 56      $ —        $ —        $ 124      $ —        $ 180   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

(a) In March, June, September and December 2010, Momentive Specialty Chemicals Inc. contributed receivables of $100, $100, $107 and $67, respectively to a non-guarantor subsidiary as capital contributions, resulting in a non-cash transaction. During the year ended December 31, 2010, the non-guarantor subsidiary sold $374 of the contributed receivables to affiliates of Apollo for net cash of $367. The cash proceeds were returned to Momentive Specialty Chemicals Inc. by the non-guarantor subsidiary as a return of capital. The sale of receivables has been included within cash flows from operating activities on the Combined non-guarantor subsidiaries. The return of the cash proceeds from the sale of receivables has been included as a financing outflow and an investing inflow on the Combined Non-Guarantor Subsidiaries and Momentive Specialty Chemicals Inc., respectively.

 

MOMENTIVE SPECIALTY CHEMICALS INC.

Notes to Consolidated Financial Statements

(dollars in millions)

YEAR ENDED DECEMBER 31, 2009

CONDENSED CONSOLIDATING STATEMENT OF CASH FLOWS

 

    Momentive
Specialty
Chemicals Inc.
    Subsidiary
Issuers
    Combined
Subsidiary
Guarantors
    Combined
Non-

Guarantor
Subsidiaries
    Eliminations     Consolidated  

Cash flows (used in) provided by operating activities

  $ (197   $ (16   $ —        $ 568      $ —        $ 355   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Cash flows provided by (used in) investing activities

           

Capital expenditures

    (38     —          —          (93     —          (131

Capitalized interest

    —          —          —          (5     —          (5

Purchases of debt securities, net

    —          —          —          (2     —          (2

Change in restricted cash

    —          —          —          2        —          2   

Proceeds from the return of capital from subsidiary

    392 (a)     —          —          —          (392     —     

Dividend from subsidiary

    6        —          5        —          (11     —     

Proceeds from the sale of assets

    4        —          —          —          —          4   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
    364        —          5        (98     (403     (132
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Cash flows (used in) provided by financing activities

           

Net short-term debt repayments

    (2     —          —          (8     —          (10

Borrowings of long-term debt

    587        —          —          568        —          1,155   

Repayments of long-term debt

    (690     (24     —          (690     —          (1,404

Borrowings of affiliated debt

    84        —          —          20        —          104   

Return of capital to parent

    —          —          —          (392 )(a)     392        —     

Purchase of note receivable due from parent

    —          —          —          (24     —          (24

Payments of dividends on common stock

    (10     —          (5     (6     11        (10

Long-term debt and credit facility financing fees

    (5     —          —          —          —          (5

Deconsolidation of noncontrolling interest in variable interest entity

    (24     —          —          —          —          (24

Net intercompany loan (repayments) borrowings

    (108     40        —          68        —          —     

Payment of dividends to non-controlling interest

    —          —          —          (4     —          (4
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 
    (168     16        (5     (468     403        (222
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Effect of exchange rates on cash and cash equivalents

    —          —          —          13        —          13   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

(Decrease) increase in cash and cash equivalents

    (1     —          —          15        —          14   

Cash and cash equivalents (unrestricted) at beginning of year

    23        —          —          98        —          121   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

Cash and cash equivalents (unrestricted) at end of year

  $ 22      $ —        $ —        $ 113      $ —        $ 135   
 

 

 

   

 

 

   

 

 

   

 

 

   

 

 

   

 

 

 

(a) In March, June, September, November and December 2009, Momentive Specialty Chemicals Inc. contributed receivables of $70, $85, $110, $33 and $104, respectively to a non-guarantor subsidiary as capital contributions, resulting in a non-cash transaction. During the year ended December 31, 2009, the non-guarantor subsidiary sold $402 of the contributed receivables to affiliates of Apollo for net cash of $392. The cash proceeds were returned to Momentive Specialty Chemicals Inc. by the non-guarantor subsidiary as a return of capital. The sale of receivables has been included within cash flows from operating activities on the Combined non-guarantor subsidiaries. The return of the cash proceeds from the sale of receivables has been included as a financing outflow and an investing inflow on the Combined Non-Guarantor Subsidiaries and Momentive Specialty Chemicals Inc., respectively.